Skip to main content
. 2022 Sep 9;14(18):4398. doi: 10.3390/cancers14184398

Figure 6.

Figure 6

The effect of FXR overexpression combined with atorvastatin treatment on survival and migration. (A) The viability of FXR-O TSGH8301 and T24 cells treated with or without atorvastatin (20 µM) was examined by MTT assays for 24 h. (B) Wound healing migration assays were performed in control and FXR-O TSGH8301 and T24 cells treated with or without atorvastatin. The lower panel shows the quantified relative migration rate. ** p < 0.01; *** p < 0.001 compared to the control group. ## p < 0.01, ### p < 0.001 compared to the control + atorvastatin group. $$ p < 0.01; $$$ p < 0.001 compared to the FXR-O group. Scale bar = 200 μm.